A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus.

Details

Ressource 1Download: 31207934_BIB_958F299A4F67.pdf (1804.59 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_958F299A4F67
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus.
Journal
Viruses
Author(s)
Bernelin-Cottet C., Urien C., Stubsrud E., Jakob V., Bouguyon E., Bordet E., Barc C., Boulesteix O., Contreras V., Barnier-Quer C., Collin N., Trus I., Nauwynck H., Bertho N., Schwartz-Cornil I.
ISSN
1999-4915 (Electronic)
ISSN-L
1999-4915
Publication state
Published
Issued date
14/06/2019
Peer-reviewed
Oui
Volume
11
Number
6
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Abstract
The Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) induces reproductive disorders in sows and respiratory illnesses in growing pigs and is considered as one of the main pathogenic agents responsible for economic losses in the porcine industry worldwide. Modified live PRRSV vaccines (MLVs) are very effective vaccine types against homologous strains but they present only partial protection against heterologous viral variants. With the goal to induce broad and cross-protective immunity, we generated DNA vaccines encoding B and T antigens derived from a European subtype 1 strain that include T-cell epitope sequences known to be conserved across strains. These antigens were expressed either in a native form or in the form of vaccibodies targeted to the endocytic receptor XCR1 and CD11c expressed by different types of antigen-presenting cells (APCs). When delivered in skin with cationic nanoparticles and surface electroporation, multiple DNA vaccinations as a stand-alone regimen induced substantial antibody and T-cell responses, which were not promoted by targeting antigens to APCs. Interestingly, a DNA-MLV prime-boost strategy strongly enhanced the antibody response and broadened the T-cell responses over the one induced by MLV or DNA-only. The anti-nucleoprotein antibody response induced by the DNA-MLV prime-boost was clearly promoted by targeting the antigen to CD11c and XCR1, indicating a benefit of APC-targeting on the B-cell response. In conclusion, a DNA-MLV prime-boost strategy, by enhancing the potency and breadth of MLV vaccines, stands as a promising vaccine strategy to improve the control of PRRSV in infected herds.
Keywords
Animals, Antibodies, Viral/blood, Antibody Formation, Immunity, Cellular, Immunization Schedule, Organisms, Genetically Modified/genetics, Organisms, Genetically Modified/immunology, Porcine Reproductive and Respiratory Syndrome/prevention & control, Porcine respiratory and reproductive syndrome virus/genetics, Porcine respiratory and reproductive syndrome virus/immunology, Swine, T-Lymphocytes/immunology, Vaccines, Attenuated/administration & dosage, Vaccines, Attenuated/genetics, Vaccines, Attenuated/immunology, Vaccines, DNA/administration & dosage, Vaccines, DNA/genetics, Vaccines, DNA/immunology, Viral Vaccines/administration & dosage, Viral Vaccines/genetics, Viral Vaccines/immunology, DNA vaccine, PRRSV, antigen-presenting cell targeting, modified-live vaccine, pigs
Pubmed
Web of science
Open Access
Yes
Create date
24/06/2019 16:50
Last modification date
30/04/2021 6:13
Usage data